You are here

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

Last updated on April 2, 2019

FOR MORE INFORMATION
Study Location
Hospital Arquitecto Marcide de Ferrol
Ferrol, A Coruña, 15405 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Metastatic Renal Cell Carcinoma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients ≥ 18 years old and diagnosed with metastatic RCC who, in the investigator's
opinion, are candidates for starting first-line treatment with a tyrosine kinase
inhibitor according to routine clinical practice.

- Patients who have no contraindications to the treatment.

- Baseline ECOG ≤ 2.

- Patients who are able to give informed consent on their own without the need for a
legal representative.

- Committed patients who are able to complete the quality of life questionnaires and
patient diary on their own without the need for a legal representative.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who are not candidates for first-line treatment with a tyrosine kinase
inhibitor.

- Patients who are receiving the treatment as second-line or subsequent therapy.

- Untreated hypothyroidism.

- Untreated severe anaemia.

- Pregnancy or breast-feeding.

- Myocardial infarction or cerebrovascular accidents (CVA) within the last 6 months.

- Severe hepatic impairment.

- Concomitant use of potent inhibitors or inducers that interact with hepatic cytochrome
CYP3A4.

NCT02789137
Pfizer
Recruiting
Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now